Overview

Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)

Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To determine the effects of 2 months therapy with simvastatin 40mg once per day compared to placebo in a double-blind placebo-controlled study of patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
University of East Anglia
Treatments:
Simvastatin